Clinical Trial Update: An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196 [Phase 1]

View source ↗

Summary

A Phase 1 exploratory trial of SEN0014196 in early-stage Huntington's disease patients has completed, according to ClinicalTrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• SEN0014196

Snippet

Sponsor: Siena Biotech S.p.A. | Conditions: Huntington Disease | Phase 1 | Status: COMPLETED